Physician profile
Jalil Anwar
NPI 1053405084
$11,574.02
in general payments reported to CMS, 2019-2025
36 companies · $2,154 in 2025
The $2,154 reported for 2025 was more than what 77% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,733 · 2020: $997 · 2021: $1,538 · 2022: $1,611 · 2023: $1,887 · 2024: $1,654 · 2025: $2,154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,297 · Education: $398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,297.19 |
| Education | $397.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,828.19 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Astrazeneca Pharmaceuticals LP | $1,743.55 | 2019-2025 | Breztri, Airsupra, Fasenra |
| Glaxosmithkline, LLC. | $1,278.55 | 2019-2025 | Trelegy Ellipta, Nucala |
| Harmony Biosciences LLC | $1,233.02 | 2020-2025 | Wakix |
| Actelion Pharmaceuticals US, INC. | $1,068.39 | 2019-2025 | Opsumit, Uptravi |
| Grifols USA, LLC | $723.87 | 2019-2024 | Prolastin-C Liquid |
| Jazz Pharmaceuticals INC. | $545.69 | 2019-2025 | |
| Philips North America LLC | $425.33 | 2019-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Mylan Specialty L.P. | $423.91 | 2019-2024 | Yupelri |
| Takeda Pharmaceuticals U.S.A., INC. | $306.41 | 2020-2025 | Glassia |
| Inspire Medical Systems, INC. | $268.68 | 2023-2025 | Inspire |
| Merck Sharp & Dohme LLC | $209.48 | 2019-2025 | Zerbaxa, Keytruda |
| Verona Pharma, INC. | $192.92 | 2025 | Ohtuvayre |
| Baxter Healthcare | $151.19 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Metaneb System, Hillrom - Life 2000 Ventilation System |
| Insmed, INC. | $129.18 | 2025 | Arikayce |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $110.23 | 2020-2022 | |
| Novo Nordisk INC | $97.76 | 2019 | |
| Electromed, INC. | $94.23 | 2021-2025 | Smartvest |
| Viatris Specialty LLC | $87.91 | 2025 | Yupelri |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $87.13 | 2019 | |
| Advanced Respiratory, INC | $79.00 | 2020-2021 | |
| Amgen INC. | $73.11 | 2019-2025 | Tezspire |
| Bayer Healthcare Pharmaceuticals INC. | $60.51 | 2025 | |
| Pfizer INC. | $50.05 | 2019-2022 | |
| Atricure, INC. | $39.48 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $38.32 | 2019 | |
| Genzyme Corporation | $37.42 | 2019 | |
| Hologic Sales and Service, LLC | $34.67 | 2023-2024 | Acessa Provu System |
| Circassia INC. | $27.80 | 2019-2020 | |
| Lilly USA, LLC | $24.57 | 2025 | Zepbound |
| Vifor Pharma, INC. | $22.08 | 2024 | Zemaira |
| Tactile Systems Technology INC | $21.93 | 2020 | |
| Genentech USA, INC. | $20.02 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $15.43 | 2021 | |
| 3b Medical, INC. | $13.02 | 2025 | Luna |
| Janssen Pharmaceuticals, INC | $10.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jalil Anwar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.